Ozempic and GLP-1 Drug Vision Loss Lawsuits New cases are now being filed against the manufacturers of weight loss GLP-1 drugs, including Ozempic, due to the development of a significant eye condition called NAION or non-arterial anterior ischemic optic neuropathy
According to phase 2 clinical trials, retatrutide has the potential to improve cardiometabolic health, reduce cholesterol, triglyceride, and LDL, and promote fat breakdown
Larger, longer-term human trials are still needed to fully characterise these effects
Stay physically active to naturally boost your circulation and body heat
Preliminary research has explored antioxidant properties and potential effects on metabolic markers, though human clinical data remains limited compared to preclinical investigations